Patents by Inventor Barbara Forte

Barbara Forte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIDYL-AND PYRIMIDINYL-SUBSTITUTED PYRROLE-, THIOPHENE-AND FURANE-DERIVATIVES AS KINASE INHIBITORS
    Publication number: 20090099221
    Abstract: The present invention provides compounds of the formula (I), or the pharmaceutically acceptable salts thereof, wherein G, W, R2, R3, R4, R5 and R6 are as defined in the specification. Further objects of the invention are processes and intermediates for the preparation of the compounds of the formula (I), pharmaceutical compositions comprising them and methods for treating cell proliferative disorders.
    Type: Application
    Filed: March 19, 2007
    Publication date: April 16, 2009
    Applicant: NERVIANO MEDICAL SCIENCES S.r.l.
    Inventors: Ermes Vanotti, Marina Caldarelli, Alessandra Cirla, Barbara Forte, Antonella Ermoli, Maria Menichincheri, Antonio Pillan, Alessandra Scolaro
  • Heteroarylpyrrolopyridinones active as kinase inhibitors
    Publication number: 20070142415
    Abstract: Compounds represented by formula (I) wherein A, R1, R2, R3, R4, R5 and R6 are as defined in the specification or a pharmaceutically acceptable salt or solvate thereof, compositions thereof, and methods of use thereof.
    Type: Application
    Filed: December 19, 2005
    Publication date: June 21, 2007
    Applicant: Pharmacia Italia S.p.A.
    Inventors: Ermes Vanotti, Barbara Forte, Katia Martina, Maria Menichincheri, Alessandra Cirla, Paolo Orsini
  • Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
    Publication number: 20060276471
    Abstract: Pyrrolo[3,4-c]pyrazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    Type: Application
    Filed: August 11, 2006
    Publication date: December 7, 2006
    Applicant: Pfizer Italia S.r.l. (formerly Pharmacia Italia S.p.A.)
    Inventors: Daniele Fancelli, Barbara Forte, Jurgen Moll, Mario Varasi, Paola Vianello
  • Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
    Patent number: 7141568
    Abstract: Pyrrolo[3,4-c]pyrazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    Type: Grant
    Filed: July 1, 2004
    Date of Patent: November 28, 2006
    Assignee: Pfizer Italia S.r.l.
    Inventors: Daniele Fancelli, Barbara Forte, Jürgen Moll, Mario Varasi, Paola Vianello
  • Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
    Publication number: 20050032839
    Abstract: Pyrrolo[3,4-c]pyrazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    Type: Application
    Filed: July 1, 2004
    Publication date: February 10, 2005
    Applicant: Pharmacia Italia S.p.A.
    Inventors: Daniele Fancelli, Barbara Forte, Jurgen Moll, Mario Varasi, Paola Vianello
  • Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
    Publication number: 20050032869
    Abstract: Pyrazolyl-indole derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    Type: Application
    Filed: July 1, 2004
    Publication date: February 10, 2005
    Applicant: Pharmacia Italia S.p.A.
    Inventors: Daniela Berta, Barbara Forte, Sergio Mantegani, Mario Varasi, Paola Vianello